Legis Daily

Generic Substitution Noninterference Act

USA117th CongressHR-7473| House 
| Updated: 11/1/2022
Carolyn B. Maloney

Carolyn B. Maloney

Democratic Representative

New York

Cosponsors (7)
David N. Cicilline (Democratic)Mark DeSaulnier (Democratic)Jerrold Nadler (Democratic)Jamie Raskin (Democratic)Janice D. Schakowsky (Democratic)Peter Welch (Democratic)Katie Porter (Democratic)

Administrative State, Regulatory Reform, and Antitrust Subcommittee, Judiciary Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Generic Substitution Noninterference Act This bill prohibits drug manufacturers from helping or directing health care providers to limit prescriptions to brand-name drugs when generic versions are available. The Federal Trade Commission and states may enforce this bill through civil actions.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 7, 2022
Introduced in House
Apr 7, 2022
Referred to the House Committee on the Judiciary.
Nov 1, 2022
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
  • April 7, 2022
    Introduced in House
  • April 7, 2022
    Referred to the House Committee on the Judiciary.
  • November 1, 2022
    Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.

Health

Generic Substitution Noninterference Act

USA117th CongressHR-7473| House 
| Updated: 11/1/2022
Generic Substitution Noninterference Act This bill prohibits drug manufacturers from helping or directing health care providers to limit prescriptions to brand-name drugs when generic versions are available. The Federal Trade Commission and states may enforce this bill through civil actions.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 7, 2022
Introduced in House
Apr 7, 2022
Referred to the House Committee on the Judiciary.
Nov 1, 2022
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
  • April 7, 2022
    Introduced in House
  • April 7, 2022
    Referred to the House Committee on the Judiciary.
  • November 1, 2022
    Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Carolyn B. Maloney

Carolyn B. Maloney

Democratic Representative

New York

Cosponsors (7)
David N. Cicilline (Democratic)Mark DeSaulnier (Democratic)Jerrold Nadler (Democratic)Jamie Raskin (Democratic)Janice D. Schakowsky (Democratic)Peter Welch (Democratic)Katie Porter (Democratic)

Administrative State, Regulatory Reform, and Antitrust Subcommittee, Judiciary Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted